University of California Berkeley - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Market Overview

Summary

University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university's academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and transgender studies, letters and science, liberal arts, linguistics, logic and the methodology of sciencebiophysics, biostatistics, buddhist studies, cognitive science, development practice, integrative biology, interdisciplinary studies, Jewish studies program, mathematics, and others. It carries out research in partnership with academic departments, institutes and centers, museums, and field stations. The university provides educational services through its colleges and schools. UC Berkeley is headquartered in Berkeley, California, the US.

University of California Berkeley-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Scope

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of California Berkeley, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10

Novartis Enters into Agreement with University of California 11

University of California, Berkeley Enters into Agreement with Aduro Biotech 12

Licensing Agreements 13

Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13

Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14

Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15

Aduro BioTech Enters into Licensing Agreement with UCB 16

University of California Berkeley-Key Competitors 17

University of California Berkeley-Key Employees 18

University of California Berkeley-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Government and Public Interest 20

Sep 26, 2018: CZ Biohub awards USD 13.7 million for new collaborative health research 20

Aug 16, 2018: New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide 21

Aug 02, 2018: Obesity extends duration of influenza a virus shedding 23

Jul 18, 2018: St. Baldrick's foundation announces USD 19.1 million in grants to fund lifesaving childhood cancer research 24

May 14, 2018: New structure of tau protein, a key player in Alzheimer's disease 25

Jan 29, 2018: Kenneth Rainin Foundation: USD 1.7 Million to Improve IBD Patient Outcomes 26

Jan 23, 2018: Damon Runyon Cancer Research Foundation awards USD 3M to eleven innovative early career scientists 27

Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 30

Jul 19, 2017: UC Berkeley: Defense department pours USD 65 million into making CRISPR safer 32

Jul 19, 2017: DARPA: Building the Safe Genes Toolkit 34

Jul 12, 2017: Anti-CRISPR proteins decrease off-target side effects of CRISPR-Cas9 37

Jan 13, 2017: Scientists reprogram embryonic stem cells to expand their potential cell fates 39

Product News 41

Apr 11, 2018: New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold 41

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of California Berkeley, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of California Berkeley, Pharmaceuticals & Healthcare, Key Facts 2

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of California Berkeley, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of California Berkeley, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of California Berkeley, Deals By Therapy Area, 2012 to YTD 2018 8

University of California Berkeley, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 10

Novartis Enters into Agreement with University of California 11

University of California, Berkeley Enters into Agreement with Aduro Biotech 12

Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 13

Aduro BioTech Amends Licensing Agreement with University of California, Berkeley 14

Aduro BioTech Enters Into Licensing Agreement With University Of California, Berkeley 15

Aduro BioTech Enters into Licensing Agreement with UCB 16

University of California Berkeley, Key Competitors 17

University of California Berkeley, Key Employees 18

University of California Berkeley, Subsidiaries 19

You can also purchase parts of this report. Do you want to check out a section wise price list?
Thank You for submiting the form our team will reach you withing next 24 hours.
85% of our clients seek customized reports. How do you wish us to custom yours?


Products

Products

University of California Berkeley, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Testimonial

Industry Speak